Drug Discovery

Bristol-Myers Squibb completes acquisition of Amira Pharmaceuticals

The transaction was originally announced on July 21, 2011, and has met all customary regulatory approval obligations.

Drug Discovery | 09 September 2011

• Bristol-Myers Squibb

Puracyp and Promega combine cell lines and assay systems

Puracyp Inc and Promega Corporation have teamed up to provide all-inclusive kits to assess nuclear receptor activation, P450 metabolism, and cellular toxicity during the drug development process. These whole cell assay systems will identify compounds…

Drug Discovery | 02 September 2011

AllCells expands operations in Shanghai, China

AllCells LLC announced that it has completed the relocation and operational expansion of its Shanghai-based facilities. AllCells-Shanghai is now situated in Ju Ke Park near the center of the city with almost 10,000 sq ft of laboratory, production…

Drug Discovery | 02 September 2011

Novartis International BioCamp spotlights diversity

Novartis has opened its eighth annual International Biotechnology Leadership Camp (BioCamp), a three-day seminar bringing biotechnology and business experts together with 60 selected students from leading international universities in 24 countries an…

Drug Discovery | 29 August 2011

PPD names Chief Scientific Officer of BioDuro

PPD Inc announced it has appointed Jasmine (Jisong) Cui, PhD, as Chief Scientific Officer of BioDuro, A PPD company. Dr Cui will provide scientific leadership to BioDuro’s integrated drug discovery services across a range of disease areas and expan…

Drug Discovery | 17 August 2011

Abbott introduces vector-borne pathogen test to detect microorganisms carried by insects

Abbott's Ibis Biosciences has introduced a new molecular assay to detect a wide variety of vector-borne microorganisms, including those known to cause Lyme Disease, Rocky Mountain Spotted Fever, Babesiosis, Ehrlichiosis and Anaplasmosis. Vector-borne…

Drug Discovery | 10 August 2011

Leading Japanese pharmaceutical scientists advance drug discovery and development

Research aims to deliver new paths to more effective drugs based on advancements in protein analysis.

Drug Discovery | 08 August 2011

AMRI appoints new director of drug discovery services in Singapore

AMRI announced that Takeshi Yura, PhD, has been promoted to Senior Director of drug discovery services at its Singapore subsidiary. In this expanded role, Dr Yura will assume overall responsibility of site management, which includes leadership of…

Drug Discovery | 04 August 2011